Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -16.208% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCOC(=O)N1CCC(Nc2c(N3CCN(c4cc(Cl)ccc4C)CC3)c(=O)c2=O)CC1
[b] Cc1cc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c2ccccc2n1
[c] COc1ccc(NC(=S)Nc2ccc(S(N)(=O)=O)cc2)c(OC)c1
Answer: b. Cc1cc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c2ccccc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c2ccccc2n1
Cc1cc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c2ccccc2n1
N-(2-methylquinolin-4-yl)-3-morpholin-4-ylsulfonylbenzamide